Mary C. Mathias

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

UK Experience of Children With Inhibitors in Severe Haemophilia B: A Report by the UKHCDO Paediatric Working Party.

UK Experience of Children With Inhibitors in Severe Haemophilia B: A Report by the UKHCDO Paediatric Working Party.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 06, 2026

Staged mechanical circulatory support in paediatric HIT: Bivalirudin anticoagulation across ECMO, VAD, and cardiac transplantation.

Staged mechanical circulatory support in paediatric HIT: Bivalirudin anticoagulation across ECMO, VAD, and cardiac transplantation.

Journal: Perfusion

Published: December 27, 2025

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes.

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes.

Journal: Pediatric blood & cancer

Published: December 23, 2025

International Practices in Managing Preconception, Pregnancy and Childbirth in Women With Glanzmann Thrombasthenia: A Survey From the European Association of Haemophilia and Allied Disorders (EAHAD).

International Practices in Managing Preconception, Pregnancy and Childbirth in Women With Glanzmann Thrombasthenia: A Survey From the European Association of Haemophilia and Allied Disorders (EAHAD).

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: September 08, 2025

Overdose of low molecular weight heparin in an infant with stage 5 chronic kidney disease treated with hemofiltration.

Overdose of low molecular weight heparin in an infant with stage 5 chronic kidney disease treated with hemofiltration.

Journal: Pediatric nephrology (Berlin, Germany)

Published: May 21, 2025

European Management of Glanzmann's Thrombasthenia: A Survey of Current Clinical Practice.

European Management of Glanzmann's Thrombasthenia: A Survey of Current Clinical Practice.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: March 26, 2025

Post hoc analysis of bleeding episodes and clinically relevant pharmacokinetic parameters among children <12 years old with severe hemophilia A receiving once-weekly efanesoctocog alfa prophylaxis in the XTEND-Kids phase 3 multinational trial.

Post hoc analysis of bleeding episodes and clinically relevant pharmacokinetic parameters among children <12 years old with severe hemophilia A receiving once-weekly efanesoctocog alfa prophylaxis in the XTEND-Kids phase 3 multinational trial.

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 06, 2025

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.

Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.

Journal: The New England journal of medicine

Published: August 30, 2023

A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia B.

A new population pharmacokinetic model for recombinant factor IX-Fc fusion concentrate including young children with haemophilia B.

Journal: British journal of clinical pharmacology

Published: May 25, 2023

Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A-Final efficacy and safety results from the NuProtect study.

Journal: European journal of haematology

Published: March 17, 2023

Long-term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients.

Long-term immunogenicity, efficacy and tolerability of simoctocog alfa in patients with severe haemophilia A who had completed the NuProtect study in previously untreated patients.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: February 03, 2023

Design of a Real-World Observational Study in Previously Untreated and Minimally Treated Hemophilia A Patients: Protect-NOW.

Design of a Real-World Observational Study in Previously Untreated and Minimally Treated Hemophilia A Patients: Protect-NOW.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: January 03, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026